· Periodic Report
Q3 profit from the main business KRW 52.6 million, down 96.7% from a year earlier
Polaris AI Pharma sold KRW 11.9 billion in Q3 and earned KRW 52.6 million from its main business, down 96.7% from a year earlier and 93.2% from the prior quarter.